Azithromycin Therapy for Multiple Eruptive Milia: A Report of a Case, New Treatment Option, and Review of the Literature

10.5580/1f46 ◽  
2009 ◽  
Vol 7 (1) ◽  
2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Elpis Mantadakis ◽  
Emmanouela Tsouvala ◽  
Savas Deftereos ◽  
Vassilios Danielides ◽  
Athanassios Chatzimichael

Propranolol has emerged as a new treatment option for infantile hemangiomas. We describe a 20-month-old boy with a large right parotid hemangioma diagnosed at the age of 37 days. Starting at the age of 2.5 months, he received oral propranolol for 6.5 months. Although the mass regressed, it recurred when propranolol was discontinued. He was successfully retreated at the age of 11 months with propranolol for another 5.5 months without further recurrences. Treatment was tolerated well. Our paper and a review of the literature demonstrate that propranolol appears to be safe and effective for symptomatic infantile parotid gland hemangiomas.


Vascular ◽  
2007 ◽  
Vol 15 (4) ◽  
pp. 226-230 ◽  
Author(s):  
Saskia van der Meer ◽  
Clark Zeebregts ◽  
Ignace Tielliu ◽  
Eric Verhoeven ◽  
Jan van den Dungen

Patients diagnosed with steal syndrome after hemodialysis access surgery have a few options for symptom relief while maintaining vascular access. These include fistula lengthening, banding, distal revascularization with interval ligation (DRIL), revision using distal inflow (RUDI) or proximalization of the arterial inflow (PAI). Two cases are described in which a modified DRIL procedure without interval ligation was used to relieve steal syndrome, leaving the arterial supply of an ischemic hand not entirely dependent upon a bypass. Furthermore, a review of the literature is presented in order to elucidate this relatively new treatment option as a viable means to improve hand perfusion while maintaining a functional fistula.


2005 ◽  
Vol 114 (9) ◽  
pp. 677-680 ◽  
Author(s):  
Brian T. Andrews ◽  
Douglas K. Trask

Objectives: Oral melanoacanthoma is a rare condition that presents as a pigmented, painful lesion, most commonly on the buccal mucosa. Argon plasma coagulation is a new treatment option for benign oral lesions and is hypothesized to be efficacious for this rare mucosal disorder. Methods: Treatment of a case and a review of the English-language literature were performed. Results: One patient received a diagnosis of oral melanoacanthoma, and argon plasma coagulation treatment resulted in ablation of the lesion with excellent mucosal healing. A review of the literature demonstrated that this lesion is most commonly associated with black (90.9%), adult female (69.7%) patients and is most commonly located on the buccal mucosa (64.7%). Conclusions: Oral melanoacanthoma is a rare, benign mucosal lesion that may require surgical intervention for symptomatic relief. Argon plasma coagulation is a relatively safe and effective means of treating this lesion. Argon plasma coagulation treatment may be expanded to include other benign, superficial lesions of the oral mucosa.


2019 ◽  
Vol 60 (3) ◽  
Author(s):  
Alba Calleja Algarra ◽  
Raquel Aragón Miguel ◽  
Virginia Velasco Tamariz ◽  
Marta Prieto Barrios ◽  
Juan José Andrés Lencina ◽  
...  

2009 ◽  
Vol 119 (9) ◽  
pp. 1844-1847 ◽  
Author(s):  
Stacey L. Halum ◽  
David L. Sycamore ◽  
Bryan R. McRae

2005 ◽  
Vol 78 (927) ◽  
pp. 236-241 ◽  
Author(s):  
W Harms ◽  
R Krempien ◽  
C Grehn ◽  
C Berns ◽  
F W Hensley ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (8) ◽  
pp. e0161116 ◽  
Author(s):  
Megan L. Lloyd ◽  
Nurul Hod ◽  
Jothsna Jayaraman ◽  
Elizabeth A. Marchant ◽  
Lukas Christen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document